AI-Powered navigation aims to pinpoint tiny lung nodules during surgery
NCT ID NCT07682012
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a device called the LungVision system, which uses artificial intelligence to help surgeons locate small lung nodules during minimally invasive surgery. The system combines CT scans with live X-ray images to guide a tool to the nodule, then injects a dye to mark it for removal. The trial involves 14 adults aged 18 to 65 who are already scheduled for lung nodule surgery, and it measures how often the system successfully finds the nodule, how long it takes, and any complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LungVision System (AI-augmented fluoroscopic navigation device)
What this could lead to
If successful, this AI-guided navigation could make lung nodule surgery more precise and reduce the need for extra radiation or preoperative procedures.
What could go wrong
This is a small pilot study with only 14 participants, so results may not apply to everyone. The system's accuracy and safety need confirmation in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Default Nudge for Cancer Screening Adherence - NCT07682220
- EGFR-Mutant NSCLC Study NCT07680907
- EP0057 + Olaparib for Lung, Bladder, Prostate Ca NCT02769962
- LLD vs CT-Guided Lung Nodule Localization Trial NCT07675889
- Liquid Biopsy in NSCLC: NCT04566432
- AI-ROSE for Lung Cancer Diagnosis Trial (NCT07662967)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tri-Service General Hospital
Taipei, Taiwan, 114202, Taiwan